课题基金 / 基金详情

Development of Chiral Ferrocenyl Compounds including Hetero Atoms and Their Use in Asymenetric Synthesis

Development of Chiral Ferrocenyl Compounds including Hetero Atoms and Their Use in Asymenetric Synthesis
含杂原子的手性二茂铁基化合物的开发及其在不对称合成中的应用
批准号:
09450340
负责人:
UEMURA Sakae
金额:
$8.13万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

UEMURA Sakae的其他基金

相关文献

中文摘要
翻译
我们发展了一种用手性二茂铁硒试剂将手性化合物引入有机分子的方法。这些试剂适用于手性化合物如联烯、4-烷基-1-亚烷基环己烷、b-羟烷基硒醚、烯丙醇和烯丙胺的不对称合成。在本报告中,我们提出了新的方法来制备几个具有高立体选择性的杂环。使用光学活性的2-[1-(二甲氨基)乙基]二茂铁硒基阳离子进行烯酸、烯醇和烯基二氢硒的不对称分子内硒环化反应,分别以良好至优异的化学产率(高达97%)和非常高的非对映选择性(高达98%de)顺利地得到相应的含内酯、环醚和N-杂环的有机硒基部分。反阴离子的性质对环化反应的非对映选择性有显著影响,PF_6和BE_4分别对烯酸和烯醇的非对映选择性最好,而对烯基醚的非对映选择性最好。环化反应的合理反应方案,其中手性selenylating剂的方法的碳-碳双键的基板从体积较小的方向,以提供一个手性episelenonium离子,然后由亲核试剂的分子内背面攻击。
英文摘要
We have developed the methodology to introduce chilalities into organic molecules using chiral ferrocenylselenium reagents. These reagents are applicable to asymmetric synthesis of chiral compounds such as allenes, 4-alkyl-1-alkylidenecyclohexanes, b-hydroxyalkyl selenides, allylic alcohols, and allylic amines. In this report we present new methodology to prepare several heterocycles with a high stereoselectivity. Asymmetric intramolecular selenocyclization of alkenoic acids, alkenols, and alkenyl urethanes using optically active 2-[1-(dimethylamino)ethyl]ferrocenylselenenyl cations proceeds smoothly to give the corresponding organoselenenyl moiety containing lactones, cyclic ethers, and N-heterocycles, respectively, in good to excellent chemical yields (up to 97%) with very high diastereoselectivities (up to 98% de). The nature of counter anions of the selenenylating agents affected remarkably the diastereoselectivity of the cyclization, PF_6 and BE_4 being revealed to be the best for that of alkenoic acids and alkenols and that of alkenyl urethanes, respectively. The plausible reaction scheme for cyclization is presented where a chiral selenenylating agent approaches the carbon-carbon double bond of the substrate from the less bulky direction to afford a chiral episelenonium ion followed by an intramolecular back side attack of a nucleophile.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
H.Takada: "Highly Selective Asymmetric Intralmolecular Selenocyclization" Phosphorus Sulphur and Silicon. 136, 137, 138合巻. 629-632 (1998)
H.Takada:“高度选择性不对称分子内硒环化”,磷硫和硅,136、137、138 卷(1998 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Nishibayashi 他1名: "Asymmetric Synthesis. Graphical Abstracts and Experimental Methods" 講談社サイエンティフィク(株) Ed.by米光 宰, (1998)
Y. Nishibayashi 和其他 1 人:“不对称合成。图形摘要和实验方法”讲谈社科学有限公司,Osamu Yonemitsu 编,(1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiaki Nishibayashi: "Highly Selective Asymmetric Intramolecular Selenocyclization" J.Chem.Soc., Chem.Commun.2321-2322 (1995)
Yoshiaki Nishibayashi:“高度选择性不对称分子内硒环化”J.Chem.Soc.,Chem.Commun.2321-2322 (1995)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Risk perception about education-research institute and improvement of reliability on relevant information
    • 批准号:
      15069203
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $5.5万
    • 财政年份:
      2003
    • 负责人:
      UEMURA Sakae
    • 依托单位:
    Development of Novel Molecular Functions of γ-Cyclodextrin-Bicapped C60 Supramolecular Complex and Supermacroheterocyccs with C60
    • 批准号:
      13305062
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $35.28万
    • 财政年份:
      2001
    • 负责人:
      UEMURA Sakae
    • 依托单位:
    Development of New Transition Metal-Catalyzed Systems under Oxygen
    • 批准号:
      11450345
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.47万
    • 财政年份:
      1999
    • 负责人:
      UEMURA Sakae
    • 依托单位:
    Metal Cation-Exchanged Clay-Catalyzed Organic Unit Reactions
    • 批准号:
      07555279
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $1.6万
    • 财政年份:
      1995
    • 负责人:
      UEMURA Sakae
    • 依托单位: